<DOC>
	<DOCNO>NCT01355068</DOCNO>
	<brief_summary>In study , bioequivalence Epanutin Infatabs® 50 mg ( source Germany ) Dilantin Infatabs® 50 mg ( sourced Australia ) assess . This intended pivotal bioequivalence study .</brief_summary>
	<brief_title>A Study Assess Epanutin Infatabs 50 mg From Germany Are Similar Dilantin Infatabs 50 mg From Australia</brief_title>
	<detailed_description />
	<mesh_term>Phenytoin</mesh_term>
	<criteria>Healthy male and/or female subject age 21 55 year , inclusive . An informed consent document sign date subject . Evidence history clinically significant abnormality . Any condition possibly affect drug absorption ( e.g . gastrectomy ) .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>phenytoin</keyword>
	<keyword>chewable tablet</keyword>
	<keyword>dilantin</keyword>
	<keyword>epanutin</keyword>
	<keyword>infatabs</keyword>
	<keyword>bioequivalence</keyword>
	<keyword>Partial seizure</keyword>
	<keyword>Tonic-clonic seizure</keyword>
</DOC>